Waldrop Jacob A. 4
4 · Sanara MedTech Inc. · Filed Mar 23, 2026
Research Summary
AI-generated summary of this filing
Sanara MedTech (SMTI) COO Jacob Waldrop Receives Restricted Stock Award
What Happened
- Jacob A. Waldrop, Chief Operating Officer of Sanara MedTech, was granted 13,956 restricted shares (transaction code A) on 2026-03-22. The grant is reported at $0.00 per share (award/compensation), not an open-market purchase or sale.
Key Details
- Transaction date: 2026-03-22; Form 4 filed 2026-03-23 (timely).
- Shares granted: 13,956 restricted shares; reported price: $0.00.
- Transaction type: Award/Grant (code A) under the Sanara MedTech 2024 Omnibus Long-Term Incentive Plan.
- Vesting: One-third vests on March 22 of 2027, 2028 and 2029, subject to continued employment (see footnote F1).
- Shares owned after the transaction: Not specified in the provided filing details.
- Filing accession: 0001493152-26-012181.
Context
- This is a compensation award (restricted stock) that vests over time and depends on continued employment; it is not an immediate market buy or sell. Such awards are common executive compensation and do not by themselves indicate insider buying or selling intent until/if shares vest and are sold.
Insider Transaction Report
Form 4
Waldrop Jacob A.
Chief Operating Officer
Transactions
- Award
Common Stock
[F1]2026-03-22−13,956→ 24,755 total
Footnotes (1)
- [F1]Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 22, 2027, 2028 and 2029, respectively, provided that the reporting person is employed by the Issuer through each such date.
Signature
/s/ Jacob A. Waldrop|2026-03-23